Version 2024
Billable Code

2024 ICD-10-CM Procedure Code 3E013GC

Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach

ICD-10-PCS Code:
3E013GC
ICD-10-PCS Code for:
Introduction of Oth Therap Subst into Subcu, Perc Approach
Is Billable?
Yes - Valid for Submission
Code Navigator:

3E013GC is a billable procedure code used to specify the performance of introduction of other therapeutic substance into subcutaneous tissue, percutaneous approach. The code is valid for the year 2024 for the submission of HIPAA-covered transactions.

3E013GC PCS Table

In an PCS table each code is represented by up seven alphanumeric characters, with each character in the table respresenting different aspects of the procedure. In the table provided below, each row represents an individual character and includes information about the character's position, designation, label, and procedure notes. For this PCS table the procedure code is in the administration section and is part of the physiological systems and anatomical regions body system, classified under introduction operation. The applicable bodysystem/region for this procedure code is subcutaneous tissue.

Position Designation Character Label Procedures Notes
1 Section 3 Administration
2 Body System E Physiological Systems and Anatomical Regions
3 Operation 0 Introduction

Involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4 BodySystem/Region 1 Subcutaneous Tissue  
5 Approach 3 Percutaneous

Involves:
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

6 Substance G Other Therapeutic Substance Includes:
  • Idarucizumab, Pradaxa(R)(dabigatran) reversal agent
  • Praxbind(R) (idarucizumab), Pradaxa(R)(dabigatran) reversal agent
7 Qualifier C Other Substance

Replaced Code

3E013GC was replaced in the 2024 ICD-10-PCS code set with the code(s):

  • XW01318 - Introduce Daratumumab/Hyaluronid in Subcu, Perc, New Tech 8
  • XW01318 - Introduce Daratumumab/Hyaluronid in Subcu, Perc, New Tech 8
  • XW01397 - Introduce Satralizum-mwge in Subcu, Perc, New Tech 7
  • XW01397 - Introduce Satralizum-mwge in Subcu, Perc, New Tech 7
  • XW01397 - Introduce Satralizum-mwge in Subcu, Perc, New Tech 7
  • XW013F5 - Introduce New Tech Therap in Subcu, Perc, New Tech 5
  • XW013F5 - Introduce New Tech Therap in Subcu, Perc, New Tech 5
  • XW013F5 - Introduce New Tech Therap in Subcu, Perc, New Tech 5
  • XW013W5 - Introduce Caplacizumab in Subcu, Perc, New Tech 5
  • XW013W5 - Introduce Caplacizumab in Subcu, Perc, New Tech 5
  • XW013W5 - Introduce Caplacizumab in Subcu, Perc, New Tech 5
  • XW013W5 - Introduce Caplacizumab in Subcu, Perc, New Tech 5
  • XW013W5 - Introduce Caplacizumab in Subcu, Perc, New Tech 5
  • XW01X27 - Introduce Bromln Proteolyt Enzy in Subcu, Extern, New Tech 7
  • XW01X27 - Introduce Bromln Proteolyt Enzy in Subcu, Extern, New Tech 7
  • XW01X27 - Introduce Anacaulase-bcdb in Subcu, Extern, New Tech 7

Clinical Classification

Other ICD-10-PCS Codes Used for Introduction Subcutaneous Tissue

What is ICD-10-PCS?

The ICD-10 Procedure Coding System (ICD-10-PCS) is a catalog of procedural codes used by medical professionals for hospital inpatient healthcare settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates. The 2024 ICD-10-PCS codes are to be used for discharges occurring from October 1, 2023 through September 30, 2024.

Each ICD-10-PCS code has a structure of seven alphanumeric characters and contains no decimals. The first character defines the major "section". Depending on the "section" the second through seventh characters mean different things.